title: Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.
abstract: This review article discusses recent work on the melatonin-mediated circadian regulation and integration of molecular, dietary, and metabolic signaling mechanisms involved in human breast cancer growth and the consequences of circadian disruption by exposure to light at night (LAN). The antiproliferative effects of the circadian melatonin signal are mediated through a major mechanism involving the activation of MT(1)  melatonin receptors expressed in human breast cancer cell lines and xenografts. In estrogen receptor (ERα+) human breast cancer cells, melatonin suppresses both ERα mRNA expression and estrogen-induced transcriptional activity of the ERα via MT(1) -induced activation of G(αi2)  signaling and reduction of 3',5'-cyclic adenosine monophosphate (cAMP) levels. Melatonin also regulates the transactivation of additional members of the steroid hormone/nuclear receptor super-family, enzymes involved in estrogen metabolism, expression/activation of telomerase, and the expression of core clock and clock-related genes. The anti-invasive/anti-metastatic actions of melatonin involve the blockade of p38 phosphorylation and the expression of matrix metalloproteinases. Melatonin also inhibits the growth of human breast cancer xenografts via another critical pathway involving MT(1) -mediated suppression of cAMP leading to blockade of linoleic acid uptake and its metabolism to the mitogenic signaling molecule 13-hydroxyoctadecadienoic acid (13-HODE). Down-regulation of 13-HODE reduces the activation of growth factor pathways supporting cell proliferation and survival. Experimental evidence in rats and humans indicating that LAN-induced circadian disruption of the nocturnal melatonin signal activates human breast cancer growth, metabolism, and signaling provides the strongest mechanistic support, thus far, for population and ecological studies demonstrating elevated breast cancer risk in night shift workers and other individuals increasingly exposed to LAN.
authors: Laboratory of Chrono-Neuroendocrine Oncology, Tulane University School of Medicine, New Orleans, LA, USA. dblask@tulane.edu
authors: David E
authors: DE
authors: Blask
authors: Steven M
authors: SM
authors: Hill
authors: Robert T
authors: RT
authors: Dauchy
authors: Shulin
authors: S
authors: Xiang
authors: Lin
authors: L
authors: Yuan
authors: Tamika
authors: T
authors: Duplessis
authors: Lulu
authors: L
authors: Mao
authors: Erin
authors: E
authors: Dauchy
authors: Leonard A
authors: LA
authors: Sauer
references: Breast Cancer Res Treat. 2009 Nov;118(2):293-305
references: 18979234
references: Lancet Oncol. 2007 Dec;8(12):1065-6
references: 19271347
references: J Pineal Res. 2008 Nov;45(4):476-88
references: 18705646
references: Breast Cancer Res Treat. 2005 May;91(1):47-60
references: 15868431
references: Cancer Lett. 2003 Jan 10;189(1):49-57
references: 12445677
references: Mol Endocrinol. 1994 Dec;8(12):1681-90
references: 7708056
references: J Circadian Rhythms. 2008 Mar 11;6:4
references: 18334030
references: Environ Health Perspect. 2007 Sep;115(9):1357-62
references: 17805428
references: J Pineal Res. 2002 Mar;32(2):112-9
references: 12071468
references: Cancer Causes Control. 2010 Dec;21(12):2059-68
references: 20680434
references: Breast Cancer Res Treat. 2004 Apr;84(3):247-50
references: 15026622
references: Cancer Lett. 2004 Dec 8;216(1):73-80
references: 15500950
references: Epidemiology. 2001 Jan;12(1):74-7
references: 11138824
references: Int J Epidemiol. 2009 Aug;38(4):963-70
references: 19380369
references: Cancer Res. 2004 Nov 1;64(21):7879-85
references: 15520194
references: Neuro Endocrinol Lett. 2003 Dec;24(6):440-4
references: 15073572
references: Cell. 2008 Jul 25;134(2):329-40
references: 18662547
references: Trends Endocrinol Metab. 2007 Jan-Feb;18(1):4-11
references: 17140805
references: Mol Cell Endocrinol. 2002 Jun 28;192(1-2):147-56
references: 12088876
references: Int J Cancer. 2006 Jan 15;118(2):274-8
references: 16080194
references: Cancer Causes Control. 2001 Apr;12(3):279-87
references: 11405333
references: Mol Cell Endocrinol. 2001 May 15;176(1-2):111-20
references: 11369450
references: J Comp Neurol. 1999 Apr 5;406(2):171-82
references: 10096604
references: Cancer Res. 2003 Nov 15;63(22):7545-52
references: 14633665
references: Cancer Res. 1997 Mar 15;57(6):1199-205
references: 9067293
references: Curr Top Med Chem. 2002 Feb;2(2):113-32
references: 11899096
references: Cancer Res. 2003 Sep 1;63(17):5454-61
references: 14500381
references: Mol Cell Endocrinol. 1991 Aug;79(1-3):C153-8
references: 1936532
references: Cancer Lett. 2004 Jun 8;209(1):25-35
references: 15145518
references: Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1528-37
references: 17686888
references: Integr Cancer Ther. 2009 Dec;8(4):347-53
references: 20042410
references: Cancer Res. 1988 Nov 1;48(21):6121-6
references: 3167858
references: Mol Endocrinol. 1999 Dec;13(12):2025-38
references: 10598579
references: Integr Cancer Ther. 2009 Dec;8(4):337-46
references: 20050373
references: Nat Rev Neurosci. 2003 Aug;4(8):649-61
references: 12894240
references: Cancer Lett. 2006 Apr 28;235(2):266-71
references: 15950374
references: J Pineal Res. 2003 Oct;35(3):204-11
references: 12932205
references: J Natl Cancer Inst. 2005 Jul 20;97(14):1084-7
references: 16030307
references: J Biol Chem. 2004 Sep 10;279(37):38294-302
references: 15229223
references: J Pineal Res. 2009 Aug;47(1):23-31
references: 19522736
references: Science. 2002 Feb 8;295(5557):1070-3
references: 11834835
references: J Natl Cancer Inst. 2001 Oct 17;93(20):1563-8
references: 11604480
references: Am J Pathol. 2003 Oct;163(4):1405-16
references: 14507648
references: Sleep Med Rev. 2009 Aug;13(4):257-64
references: 19095474
references: PLoS One. 2009 May 21;4(5):e5650
references: 19478857
references: J Pineal Res. 2005 May;38(4):231-9
references: 15813899
references: Am J Epidemiol. 1987 Apr;125(4):556-61
references: 3548332
references: Lab Anim Sci. 1997 Oct;47(5):511-8
references: 9355094
references: Cancer Detect Prev. 2006;30(2):118-28
references: 16647824
references: Cancer Res. 1999 Sep 15;59(18):4693-701
references: 10493527
references: Nat Rev Cancer. 2003 Aug;3(8):623-7
references: 12894250
references: Sleep Med Rev. 2005 Feb;9(1):11-24
references: 15649735
references: Cancer Lett. 1999 Oct 1;144(2):131-6
references: 10529012
references: Cancer Res. 2009 Mar 1;69(5):1702-5
references: 19244112
references: Osterr Z Onkol. 1976 Sep 13;3(3):51-60
references: 794798
references: Cell. 2002 Oct 4;111(1):41-50
references: 12372299
references: Breast Cancer Res. 2010;12(6):R107
references: 21167057
references: Jpn J Cancer Res. 1998 Nov;89(11):1099-103
references: 9914776
references: J Biol Rhythms. 2005 Oct;20(5):391-403
references: 16267379
references: Cancer Res. 2005 Dec 1;65(23):11174-84
references: 16322268
references: J Pineal Res. 2006 Nov;41(4):297-305
references: 17014686
references: J Pineal Res. 1991 Jan;10(1):36-42
references: 2056430
references: Mol Cell Endocrinol. 1998 Jun 25;141(1-2):53-64
references: 9723886
references: Jpn J Clin Oncol. 2000 Dec;30(12):529-33
references: 11210161
references: Biochem Pharmacol. 2001 Jun 15;61(12):1455-62
references: 11377374
references: J Natl Cancer Inst. 2001 Oct 17;93(20):1557-62
references: 11604479
references: Endocrine. 2005 Jul;27(2):179-88
references: 16217131
references: J Pineal Res. 2005 May;38(4):217-22
references: 15813897
references: J Natl Cancer Inst. 2008 Jun 18;100(12):898-905
references: 18544743